Ipek Erdogan-Trinkaus - Chief Commercial Officer at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
ETON on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ipek Erdogan-Trinkaus since 10 Feb 2025

Holdings reported by Ipek Erdogan-Trinkaus for Eton Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,403 $40,610 $16.90 12 Dec 2025 Direct
Restricted Stock Units 149,734 12 Jan 2026 Direct Common Stock
Employee Stock Option (Right to Buy) 123,878 12 Jan 2026 Direct Common Stock

Transactions reported by Ipek Erdogan-Trinkaus for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.